Illumina’s chief executive Francis deSouza was awarded $26.7mn in total pay in 2022, almost double the amount in the previous year, ahead of a proxy fight with activist investor Carl Icahn.
The disclosure in a preliminary proxy filing on Thursday shows the world’s biggest genome sequencing company issued a special grant of stock options worth $12.5mn to deSouza as a retention incentive due to the “highly competitive talent environment”.
DeSouza was paid $14.3mn in 2021. The 86…
Read the full article here
